Ilmari Ahonen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ilmari Ahonen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jaakko Nevalainen
Faculty of Social Sciences, Tampere University, Tampere, Finland
3 shared publications Denis Larocque
HEC Montreal, Dept Decis Sci, Montreal, PQ, Canada
2 shared publicationsEva Oswald
Discovery Services, Charles River, Freiburg, Germany
1 shared publicationH. Tähti
University of Tampere
1 shared publicationHannu-Pekka Schukov
1 shared publicationJulia Schüler
Discovery Services, Charles River, Freiburg, Germany
1 shared publication
Latest Publications
- 1 April 2019
- Published by Elsevier in Computational Statistics & Data Analysis
- Vol. 132, 212-224
Prediction with a flexible finite mixture-of-regressions
- 1 April 2019
- Published by Elsevier in Computational Statistics & Data Analysis
- Vol. 132, 212-224
Prediction with a flexible finite mixture-of-regressions
- Open Access
- 26 July 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 6600
A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues
Organotypic, three-dimensional (3D) cancer models have enabled investigations of complex microtissues in increasingly realistic conditions. However, a drawback of these advanced models remains the poor biological relevance of cancer cell lines, while higher clinical significance would be obtainable with patient-derived cell cultures. Here, we describe the generation and data analysis of 3D microtissue models from patient-derived xenografts (PDX) of non-small cell lung carcinoma (NSCLC). Standard of care anti-cancer drugs were applied and the altered multicellular morphologies were captured by confocal microscopy, followed by automated image analyses to quantitatively measure phenotypic features for high-content chemosensitivity tests. The obtained image data were thresholded using a local entropy filter after which the image foreground was split into local regions, for a supervised classification into tumor or fibroblast cell types. Robust statistical methods were applied to evaluate treatment effects on growth and morphology. Both novel and existing computational approaches were compared at each step, while prioritizing high experimental throughput. Docetaxel was found to be the most effective drug that blocked both tumor growth and invasion. These effects were also validated in PDX tumors in vivo. Our research opens new avenues for high-content drug screening based on patient-derived cell cultures, and for personalized chemosensitivity testing.
- 26 July 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 6600
Open AccessA high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues
Organotypic, three-dimensional (3D) cancer models have enabled investigations of complex microtissues in increasingly realistic conditions. However, a drawback of these advanced models remains the poor biological relevance of cancer cell lines, while higher clinical significance would be obtainable with patient-derived cell cultures. Here, we describe the generation and data analysis of 3D microtissue models from patient-derived xenografts (PDX) of non-small cell lung carcinoma (NSCLC). Standard of care anti-cancer drugs were applied and the altered multicellular morphologies were captured by confocal microscopy, followed by automated image analyses to quantitatively measure phenotypic features for high-content chemosensitivity tests. The obtained image data were thresholded using a local entropy filter after which the image foreground was split into local regions, for a supervised classification into tumor or fibroblast cell types. Robust statistical methods were applied to evaluate treatment effects on growth and morphology. Both novel and existing computational approaches were compared at each step, while prioritizing high experimental throughput. Docetaxel was found to be the most effective drug that blocked both tumor growth and invasion. These effects were also validated in PDX tumors in vivo. Our research opens new avenues for high-content drug screening based on patient-derived cell cultures, and for personalized chemosensitivity testing.
- 2 April 2016
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 8 (2) , 217-228
Morphological Clustering of Cell Cultures Based on Size, Shape, and Texture Features
High content screening for drug discovery in cancer research relies increasingly on cell-based models, using microscopic imaging as a primary readout. In combination, microscopic imaging and cell culturing provide powerful tools for studying cancer-relevant cell biology in vitro. As a result, an enormous amount of complex biometric image data is generated that can be used for high throughput and high content analyses. We present a method for computationally efficient and flexible quantification of multicellular structures or tumor spheroids, conducted in a semi-unsupervised manner. Our phenotypic clustering approach is based on morphological features, in particular, on size and novel shape and texture features. It consists of multiple automated steps in which the information characterizing the most relevant morphological features is first extracted from the images, the dimension of the features is reduced, and finally, structures are clustered into biologically meaningful groups. Local central moments and local binary operators characterize the texture, whereas shape features are obtained by an alignment to elliptical and smooth reference shapes. Using simulation studies, we show that the cluster identification performs well and demonstrates good repeatability in the presence of random orientation, size, rescaling, and texture. We show how the method can be applied to an actual high-content imaging dataset to find an intuitive and flexible summary of high content screens, not achievable with existing tools. Supplementary materials for this article are available online.
- 2 April 2016
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 8 (2) , 217-228
Morphological Clustering of Cell Cultures Based on Size, Shape, and Texture Features
High content screening for drug discovery in cancer research relies increasingly on cell-based models, using microscopic imaging as a primary readout. In combination, microscopic imaging and cell culturing provide powerful tools for studying cancer-relevant cell biology in vitro. As a result, an enormous amount of complex biometric image data is generated that can be used for high throughput and high content analyses. We present a method for computationally efficient and flexible quantification of multicellular structures or tumor spheroids, conducted in a semi-unsupervised manner. Our phenotypic clustering approach is based on morphological features, in particular, on size and novel shape and texture features. It consists of multiple automated steps in which the information characterizing the most relevant morphological features is first extracted from the images, the dimension of the features is reduced, and finally, structures are clustered into biologically meaningful groups. Local central moments and local binary operators characterize the texture, whereas shape features are obtained by an alignment to elliptical and smooth reference shapes. Using simulation studies, we show that the cluster identification performs well and demonstrates good repeatability in the presence of random orientation, size, rescaling, and texture. We show how the method can be applied to an actual high-content imaging dataset to find an intuitive and flexible summary of high content screens, not achievable with existing tools. Supplementary materials for this article are available online.
- 6 July 2015
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 26 (4) , 1867-1880
Global tests for novelty
Outlier detection covers the wide range of methods aiming at identifying observations that are considered unusual. Novelty detection, on the other hand, seeks observations among newly generated test data that are exceptional compared with previously observed training data. In many applications, the general existence of novelty is of more interest than identifying the individual novel observations. For instance, in high-throughput cancer treatment screening experiments, it is meaningful to test whether any new treatment effects are seen compared with existing compounds. Here, we present hypothesis tests for such global level novelty. The problem is approached through a set of very general assumptions, making it innovative in relation to the current literature. We introduce test statistics capable of detecting novelty. They operate on local neighborhoods and their null distribution is obtained by the permutation principle. We show that they are valid and able to find different types of novelty, e.g. location and scale alternatives. The performance of the methods is assessed with simulations and with applications to real data sets.
- 6 July 2015
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 26 (4) , 1867-1880
Global tests for novelty
Outlier detection covers the wide range of methods aiming at identifying observations that are considered unusual. Novelty detection, on the other hand, seeks observations among newly generated test data that are exceptional compared with previously observed training data. In many applications, the general existence of novelty is of more interest than identifying the individual novel observations. For instance, in high-throughput cancer treatment screening experiments, it is meaningful to test whether any new treatment effects are seen compared with existing compounds. Here, we present hypothesis tests for such global level novelty. The problem is approached through a set of very general assumptions, making it innovative in relation to the current literature. We introduce test statistics capable of detecting novelty. They operate on local neighborhoods and their null distribution is obtained by the permutation principle. We show that they are valid and able to find different types of novelty, e.g. location and scale alternatives. The performance of the methods is assessed with simulations and with applications to real data sets.
- 1 January 1991
- Published by Springer Nature
- Vol. 14, 38-40
The Effects of n-Hexane and its Metabolites on Erythrocyte and Synaptosome Membrane Acetylcholinesterase in Vitro
- 1 January 1991
- Published by Springer Nature
- Vol. 14, 38-40
The Effects of n-Hexane and its Metabolites on Erythrocyte and Synaptosome Membrane Acetylcholinesterase in Vitro